Lifestyle Changes, Erectile Dysfunction, and Female Sexual Dysfunction: Heart Health and Sexual Health

2013 ◽  
pp. 89-106
Author(s):  
Mark A. Moyad
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Female Sexual Dysfunction ◽  
Lifestyle Changes ◽  
Heart Health

Aetiology and Management of Male Erectile Dysfunction and Female Sexual Dysfunction in Patients with Cardiovascular Disease

Drugs & Aging ◽  
2005 ◽  
Vol 22 (10) ◽  
pp. 823-844 ◽  
Author(s):  
Stephen L Archer ◽  
Ferrante S Gragasin ◽  
Linda Webster ◽  
Derek Bochinski ◽  
Evangelos D Michelakis
Keyword(s):  
Cardiovascular Disease ◽  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Female Sexual Dysfunction ◽  
Male Erectile Dysfunction

The New Avatar of Female Sexual Dysfunction in ICD-11—Will It Herald a Better Future?

2019 ◽  
Vol 1 (2) ◽  
pp. 111-113
Author(s):  
Soumya Parameshwaran ◽  
Prabha S. Chandra
Keyword(s):  
Clinical Practice ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Female Sexual Dysfunction ◽  
Sexual Problems ◽  
Sexual Dysfunctions ◽  
Diagnosis And Management

Female sexual dysfunction has always had challenges related to nosological issues due to inadequate research and understanding in this area. The ICD-11 has proposed substantial changes to the classification of conditions related to sexual health. In this review, we have discussed the proposed changes, compared with other classificatory systems and discussed its implications on clinical practice and research in this field. While there have been several progressive moves in the taxonomy of sexual dysfunctions, we have expressed our views on possible changes which can help with better diagnosis and management of sexual problems in women.

Erectile dysfunction cause in men with urination disorders

2020 ◽  
Vol 1 (1) ◽  
pp. 50-59
Author(s):  
Pavel Rasner ◽  
Dmitrii Pushkar ◽  
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Health ◽  
Age Of Onset ◽  
Moscow Region ◽  
Sexual Life ◽  
Age Group ◽  
Urination Disorders ◽  
Peak Period ◽  
Age Related

Introduction. Erectile dysfunction is an urgent problem of modern urology. There is a consistent correlation between the sexual dysfunction incidence and the aging changes in the man’s body. In this study, an attempt was made to analyze the causes of the discussed correlation. An analysis comparing the data obtained with the worldwide figures and the results previously reported in Russia was performed. Materials and methods. The prospective multicenter epidemiological study was carried out using the data acquired from April 1 to May 31, 2017 during the anonymous questioning of 525 men (average age 64.2±9.93) living in Moscow, who had contacted the urologist due to urination disorders. The respondents answered the questions of the specially developed 140-point questionnaire. All demographic and medical data was taken into account, including information on comorbidities and age of onset. The IIEF, IPSS, QoL and AMS (Aging Male Screening) questionnaires were completed. Statistical processing of the results was carried out. Results. Complaints of sexual dysfunction are a relatively rare reason for the urologist’s consultation in men with LUTS living in the Moscow region. However, the survey has revealed that 39.9% of men did not consider themselves sexually active. The particularly low sexual health rate was detected in the age group over 70. The average IIEF questionnaire score for the respondents was 39.40±21.14. Less than a third of respondents reported their sexual life quality as acceptable. The correlation coefficient between the total IIEF score and the birth year was +0.422, and for the IPSS score it was -0.205. Correlations were considered significant when p<0.001. The erectile dysfunction risk increases with age, however, according to numerous publications it is not due to natural aging process, but due to severe comorbidities, particularly hypertension, infections, vascular diseases and diabetes mellitus. The patients' compliance with healthy lifestyle, abstention from smoking and regular drinking, is of great importance. In this study, the 152 of 525 (29%) respondents were smokers at the time of the survey. Strong liquor was routinely consumed by 250 respondents (47.6%), and low-alcohol beverages were consumed by 167 people (31.8%). The onset of the listed above comorbidities occurs at the age of 50–60, which makes it possible to explain the rapid ED incidence increase in the corresponding age group. The pattern identified constitutes evidence of the organic causes of erectile dysfunction. Conclusion. Analysis of the erectile dysfunction type and incidence in patients with LUTS living in the Moscow region demonstrated certain differences between the results obtained and the results of similar American and European studies. A steady trend of sexual health deterioration was observed in patients aged over 55–65. We have proved correlation between these changes and various cardiovascular diseases manifestations (CAD, hypertension), the peak period of which falls on the described age group. Comparison of the data obtained to those of 2012 has demonstrated increased severity of the “age-related” symptoms.

Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction

2006 ◽  
Vol 24 (6) ◽  
pp. 653-656 ◽  
Author(s):  
Ridwan Shabsigh ◽  
Aristotelis Anastasiades ◽  
Kimberly L. Cooper ◽  
Matthew P. Rutman
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Female Sexual Dysfunction ◽  
Voiding Symptoms

The Social Construction of Dysfunction and Disorders: What Role Does the Pharmaceutical Industry Play?

2016 ◽  
Author(s):  
Nicole Persall
Keyword(s):  
Sexual Dysfunction ◽  
Pharmaceutical Industry ◽  
Sexual Health ◽  
Female Sexual Dysfunction ◽  
New Drugs ◽  
Pharmaceutical Companies ◽  
The Social ◽  
Pharmaceutical Industries ◽  
Definition Of ◽  
Male Erectile Dysfunction

There has been widespread controversy regarding the pharmaceutical industry’s motive to promote and sell new drugs pertaining to sexual health. In this paper I will bring up a number of different authors who feel that the definition of ‘sexual health’ has been purposely redefined in order to create a market for a drug whose need is questionable. This paper investigates and raises questions about the veracity of diseases heavily promoted and marketed by the pharmaceutical industry, such as female sexual dysfunction disorder. Is it truly the female equivalent to male erectile dysfunction? Or is it the avaricious creation of pharmaceutical companies in a sly endeavor to increase sales of products like Viagra? Next, I look at the enormous impact pharmaceutical companies have had on shaping our everyday definitions of what is ‘normal’ in terms of sexual functioning. Also, the effects of standardizing diagnosis are considered, and finally, I investigate the costs of reducing sexual dysfunction to a physiological cause and how pharmaceutical industries strive to create a universalized, function-focused sexuality in which physiology dictates sexual conduct.

Gynecological diseases as predictors of female sexual dysfunction

GYNECOLOGY ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 149-154
Author(s):  
Natalia N. Stenyaeva ◽  
Dmitrii F. Chritinin ◽  
Andrei A. Chausov
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Health ◽  
Sexual Function ◽  
Sexual Functioning ◽  
Female Sexual Dysfunction ◽  
Sexual Dysfunctions ◽  
Female Sexual Function ◽  
Gynecological Diseases ◽  
Screening Assessment ◽  
Outpatient Appointments

Background. Female sexual dysfunction is extremely common and affects about half of the worlds women. Currently, the question of the relationship between gynecological morbidity in women and the characteristics of sexual activity and sexual functioning in a couple remains poorly understood. Aim. To establish gynecological diseases associated with decreased sexual functioning, sexual health disorders in women on the basis of a screening assessment when visiting the clinic. Materials and methods. We conducted a cross-sectional descriptive study of the sexual functioning of 1256 women who presented to outpatient appointments. Anamnestic and clinical methods were used, sexological testing using the Female Sexual Function Index questionnaire. Results. Based on anamnestic data, screening assessment of sexual health and sexual functioning of 1235 women who applied for outpatient appointments to a gynecological clinic, a high gynecological and extragenital morbidity was established in patients (100%). The structure of gynecological diseases is represented by female infertility (48.3%), inflammatory diseases of the genital organs (38.5%; of which salpingo-oophoritis 16.6% and vulvovaginitis 15.9%), endometriosis (13.9%) , menstrual irregularities (8.3%), as well as pain disorders (8.1%). The incidence of infections, predominantly sexually transmitted, was revealed, among them papillomatous viral infection (8.3%), genital herpes (5.3%) and chlamydia (3.7%). It was found that in gynecological patients with diseases characterized by a chronic course, inflammation, pelvic pain, menstrual and reproductive disorders, sexual functioning significantly decreases (p=0.00) and sexual health is impaired. Sexual dysfunctions were detected in 21.6% of patients, their structure is represented by isolated (39.3%) and combined (60.7%) disorders of libido, orgasm, sexual anhedonia, failure of genital response, as well as dyspareunia, vaginismus. In 33.7% of patients, preclinical forms of sexual dysfunction were identified that did not meet the criteria for sexual dysfunction (did not cause distress, were short-lived), but confirmed by the analysis of patient complaints, as well as by the results of the Female Sexual Function Index questionnaire. Conclusion. Thus, chronic gynecological diseases with inflammatory manifestations, pelvic pain, menstrual and reproductive dysfunctions are associated with decreased sexual functioning, sexual dysfunctions, and preclinical forms of sexual dysfunctions.

Sign in / Sign up

Export Citation Format

Share Document